Dr. Rachel StonePeptides for weight loss are everywhere right now — from GLP-1 agonists making headlines to lesser-known compounds circulating in biohacking and fitness communities. The category is real, the science is growing, and the results can be dramatic. But the landscape is also full of confusion, marketing hype, and genuine safety concerns.
Here’s a clear guide to what peptides actually are, which ones have evidence for weight loss, and what you need to know before considering them.
What Are Peptides?
Peptides are short chains of amino acids — essentially mini-proteins — that act as signalling molecules in the body. They bind to specific receptors and trigger precise physiological responses. Hormones like insulin, glucagon, and GLP-1 are peptides. The pharmaceutical industry has been developing synthetic peptides that mimic or enhance these natural signals for decades.
The Main Peptides Used for Weight Loss
1. GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)
These are the best-evidenced and FDA-approved weight loss peptides. Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are synthetic analogues of naturally occurring gut peptides that regulate appetite, gastric emptying, and blood glucose.
- Semaglutide (Wegovy): Average 15–17% body weight reduction over 68 weeks in the STEP trials — the most effective pharmaceutical weight loss seen in clinical trials outside of bariatric surgery
- Tirzepatide (Zepbound): Average 20–22% body weight reduction in the SURMOUNT trials — surpasses semaglutide and approaches surgical weight loss outcomes
Both are injected weekly and are available by prescription. Side effects include nausea, vomiting, constipation, and in rare cases pancreatitis or thyroid concerns.
2. CJC-1295 + Ipamorelin
This combination stimulates growth hormone (GH) release by acting on the GHRH receptor (CJC-1295) and the ghrelin receptor (Ipamorelin). Elevated GH increases lipolysis (fat breakdown), particularly from visceral fat depots, while preserving or building lean muscle.
Used extensively in anti-aging and body composition contexts. Not FDA-approved for weight loss; classified as research compounds in most countries. Requires injection.
3. AOD-9604
AOD-9604 is a modified fragment of human growth hormone (HGH) — specifically the fat-metabolising portion of the HGH molecule. It mimics the fat-burning effects of HGH without affecting blood glucose or stimulating IGF-1 production (reducing the cancer-risk concerns associated with HGH itself). Early clinical trials showed promising fat loss results, but larger Phase 3 trials were not completed. Not approved anywhere for weight loss.
4. BPC-157 (Indirect)
BPC-157 (Body Protection Compound 157) is primarily known for its healing, gut-protective, and anti-inflammatory properties rather than direct fat loss. However, its ability to reduce systemic inflammation, improve gut integrity, and support the gut-brain axis may indirectly support weight management — particularly in people whose metabolic dysfunction is driven by chronic inflammation or leaky gut.
Peptide Weight Loss Comparison
| Peptide | Weight Loss Evidence | Approval Status | Administration |
|---|---|---|---|
| Semaglutide (Wegovy) | ⭐⭐⭐⭐⭐ Excellent (15–17%) | FDA-approved | Weekly injection |
| Tirzepatide (Zepbound) | ⭐⭐⭐⭐⭐ Excellent (20–22%) | FDA-approved | Weekly injection |
| CJC-1295 + Ipamorelin | ⭐⭐⭐ Moderate (body comp) | Not approved | Daily injection |
| AOD-9604 | ⭐⭐ Early evidence | Not approved | Injection |
| BPC-157 | ⭐ Indirect/indirect | Not approved | Injection or oral |
Important Safety and Legal Considerations
- GLP-1 agonists (semaglutide, tirzepatide) are prescription medications requiring medical supervision — they cannot be bought over the counter
- Peptides like CJC-1295, Ipamorelin, and AOD-9604 are sold as “research chemicals” and are not approved for human use by any regulatory agency; their safety profiles in humans are not fully established
- Quality control with non-pharmaceutical peptides is a significant concern — what’s in the vial may not match what’s claimed on the label
- All injectable peptides carry infection risk if proper sterile technique isn’t used
Frequently Asked Questions
The best-evidenced peptides for weight loss are the FDA-approved GLP-1 agonists — semaglutide (Wegovy) at 15–17% average body weight reduction, and tirzepatide (Zepbound) at 20–22% in clinical trials. These require a prescription. Unapproved peptides like CJC-1295/Ipamorelin and AOD-9604 are used in research and anti-aging contexts for body composition, but lack the clinical evidence and safety data of approved medications.
For the approved GLP-1 agonists (semaglutide, tirzepatide), the evidence is extraordinarily strong — producing weight loss outcomes previously only seen with bariatric surgery. For other peptides like CJC-1295 and AOD-9604, the evidence is more limited but they do show genuine effects on body composition. Quality, dosing, and safety are significant concerns outside of pharmaceutical-grade GLP-1 medications.
FDA-approved GLP-1 agonists have extensive clinical safety data, though side effects are common (nausea, vomiting) and rare serious risks exist (pancreatitis, thyroid concerns). Non-approved peptides like CJC-1295 and AOD-9604 have limited human safety data, uncontrolled quality, and carry inherent risks of injecting research chemicals. Always consult a physician before using any peptide for weight loss.
Both contain semaglutide, but at different doses and for different approved uses. Ozempic is approved for type 2 diabetes at doses up to 2mg weekly. Wegovy is approved specifically for chronic weight management at a higher dose (2.4mg weekly). The higher dose in Wegovy produces greater weight loss than standard Ozempic doses.
This article is for informational purposes only. Peptides used for weight loss should only be used under appropriate medical supervision. Non-approved peptides should be approached with significant caution.
Related reading: Does Berberine Cause Weight Loss?, Best Foods for Weight Loss, How to Boost Your Metabolism.
Elena Voss
Rachel Summers
Dr. Maya Chen
